Hubner R - Search Results

1

Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?

Lamarca A, Elliott E, Barriuso J, Backen A, McNamara MG, Hubner R, Valle JW. Lamarca A, et al. Among authors: hubner r. Cancer Treat Rev. 2016 Mar;44:26-41. doi: 10.1016/j.ctrv.2016.01.005. Epub 2016 Jan 25. Cancer Treat Rev. 2016. PMID: 26855376 Review.

2

Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial.

Rothermundt C, Hubner R, Ahmad T, Gibbens I, Keyzor C, Habeshaw T, Kaye S, Gore M. Rothermundt C, et al. Among authors: hubner r. Br J Cancer. 2006 Jan 16;94(1):74-8. doi: 10.1038/sj.bjc.6602879. Br J Cancer. 2006. PMID: 16306873 Free PMC article. Clinical Trial.

3

Sunitinib for advanced pancreatic neuroendocrine tumors.

Hubner RA, Valle JW. Hubner RA, et al. Expert Rev Anticancer Ther. 2011 Dec;11(12):1817-27. doi: 10.1586/era.11.171. Expert Rev Anticancer Ther. 2011. PMID: 22117148 Review.

4

Gemcitabine plus capecitabine in unselected patients with advanced pancreatic cancer.

Hubner RA, Worsnop F, Cunningham D, Chau I. Hubner RA, et al. Pancreas. 2013 Apr;42(3):511-5. doi: 10.1097/MPA.0b013e31826c6aee. Pancreas. 2013. PMID: 23462324

5

Second-line chemotherapy in advanced biliary cancer: a systematic review.

Lamarca A, Hubner RA, David Ryder W, Valle JW. Lamarca A, et al. Among authors: hubner ra. Ann Oncol. 2014 Dec;25(12):2328-2338. doi: 10.1093/annonc/mdu162. Epub 2014 Apr 25. Ann Oncol. 2014. PMID: 24769639 Free article. Review.

6

Reply to the letter to the editor 'second-line chemotherapy in advanced biliary cancer: the present now will later be past' by Vivaldi et al.

Lamarca A, Hubner RA, Ryder WD, Valle JW. Lamarca A, et al. Among authors: hubner ra. Ann Oncol. 2014 Dec;25(12):2444-2445. doi: 10.1093/annonc/mdu382. Epub 2014 Aug 19. Ann Oncol. 2014. PMID: 25139549 Free article. No abstract available.

7

Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumors.

Valle JW, Faivre S, Hubner RA, Grande E, Raymond E. Valle JW, et al. Cancer Treat Rev. 2014 Dec;40(10):1230-8. doi: 10.1016/j.ctrv.2014.09.001. Epub 2014 Sep 16. Cancer Treat Rev. 2014. PMID: 25283354 Free article.

8

Somatostatin receptor expression in hepatocellular carcinoma: prognostic and therapeutic considerations.

Abdel-Rahman O, Lamarca A, Valle JW, Hubner RA. Abdel-Rahman O, et al. Endocr Relat Cancer. 2014;21(6):R485-93. doi: 10.1530/ERC-14-0389. Epub 2014 Oct 21. Endocr Relat Cancer. 2014. PMID: 25336571 Review.

9

To BRCA or Not to PALB.

McNamara MG, Lamarca A, Hubner RA, Valle JW. McNamara MG, et al. J Clin Oncol. 2015 Aug 10;33(23):2581-2. doi: 10.1200/JCO.2014.60.0585. Epub 2015 Jun 29. J Clin Oncol. 2015. PMID: 26124473 No abstract available.

10

Appendiceal Goblet Cell Carcinoids: Management Considerations from a Reference Peritoneal Tumour Service Centre and ENETS Centre of Excellence.

Lamarca A, Nonaka D, Lopez Escola C, Hubner RA, O'Dwyer S, Chakrabarty B, Fulford P, Valle JW. Lamarca A, et al. Neuroendocrinology. 2016;103(5):500-17. doi: 10.1159/000440725. Epub 2015 Sep 10. Neuroendocrinology. 2016. PMID: 26356507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

574 results

Search Page

Filters